ISCT 2026: Cell & Gene Therapy Manufacturing Innovations in Dublin

Key Takeaways

• The ISCT 2026 Annual Meeting will focus on advancements in cell and gene therapy.
• The meeting is scheduled for May 6-9, 2026, in Dublin, Ireland.
• Key themes include manufacturing innovations and clinical applications in cell and gene therapy.
• Catalent and AGC Biologics are highlighted as key participants with presentations and booths.

The ISCT (International Society for Cell & Gene Therapy) 2026 Annual Meeting, the largest global conference dedicated to cell and gene therapy (CGT), will take place from May 6-9, 2026, at the Convention Centre Dublin in Dublin, Ireland. This event will feature scientific presentations, abstract sessions, and networking opportunities, emphasizing the latest advancements in gene editing, cell therapies, and biomanufacturing.

The ISCT Annual Meeting is a crucial event for researchers, clinicians, and industry professionals involved in cell and gene therapy. It provides a platform to share the latest research, discuss challenges, and foster collaborations to accelerate the development and delivery of these innovative therapies to patients.

ISCT 2026 Annual Meeting Overview

The ISCT 2026 Annual Meeting serves as the largest global conference for the cell and gene therapy (CGT) field. The meeting includes scientific presentations, abstract sessions, and networking events, focusing on advancements in gene editing, cell therapies, and biomanufacturing.

IntelligenceRegulatory Impact▾

EMA and MHRA set GMP, data-integrity, and post-approval change expectations for sterile and biologics manufacturing in Europe. Regulatory relevance reads medium for manufacturing. Track inspection trends, Annex 1 alignment, and submission pathways for continuous manufacturing.

Confirmed Presentations and Key Speakers

Confirmed presentations at the ISCT 2026 Annual Meeting include:

• Frederic Cedrone (Catalent): Will present on GMP iPSC lines and manipulation workflows. His talk, titled "GMP iPSC Lines and Manipulations Workflows: from Lessons Learned to Partnerships Easing Translation to Clinic and Patient Cures," is scheduled for Thursday, May 7, 2026, from 13:30-13:45 in Theatre B, Liffey Floor (Level 1).
• Mark Flower (AGC Biologics): Will moderate a session on strategies for rare and autoimmune diseases on May 7, 2026, at 8:00 am GMT, titled "Redefining CGT Development: Strategies for Rare and Autoimmune Disease."
• Federica Mingotto (AGC Biologics): Will present a poster on integrated platforms for genetically modified T cells with lentiviral vectors (LVVs) on May 6, 2026, at 7:00 pm GMT, titled "Development of Integrated and Modular Platforms for the Manufacturing of Genetically Modified T Cells with Lentiviral Vectors (LVVs)."

IntelligenceCompetitive Intelligence▾

Competitive pressure is low on capacity and tech-transfer positioning. Benchmark which CDMOs, equipment vendors, and sponsors adopt continuous and isolator platforms first. Supplier hub and pipeline links below connect to named partners.

Exhibitor Highlights

Key exhibitors at the ISCT 2026 Annual Meeting include Catalent and AGC Biologics:

• Catalent: Booth #2204
• AGC Biologics: Booth #1910

Networking opportunities will be available at the Global Industry Networking Reception, sponsored by Catalent, on May 7, 2026, from 19:00-22:30 GMT at The Guinness Storehouse.

IntelligenceMarket Signals▾

Commercial pull is medium for manufacturing capacity, outsourcing, and supply resilience. Investment relevance is low — watch capex, licensing, and regional hub expansion.

Manufacturing and Market Context

The global cell and gene therapy CDMO market is projected to reach USD 125.09 billion by 2035, growing at a CAGR of 28.3%. Oncology currently holds the major market share by indication, with rare diseases expected to see notable expansion through 2035.

IntelligenceStrategic Takeaways▾

The ISCT 2026 Annual Meeting will focus on advancements in cell and gene therapy. The meeting is scheduled for May 6-9, 2026, in Dublin, Ireland. Key themes include manufacturing innovations and clinical applications in cell and gene therapy.

What to Watch Next

As the event approaches, keep an eye out for the release of late-breaking abstracts and the full conference program for more detailed insights into clinical trial data and emerging trends in cell and gene therapy. The official ISCT website (isctglobal.org/annual-meeting) will be the primary source for updated information.

Frequently Asked Questions

• What is the ISCT Annual Meeting?

  The ISCT Annual Meeting is the largest global conference focused on cell and gene therapy, bringing together researchers, clinicians, and industry professionals to share the latest advancements and discuss challenges in the field.

• When and where will the ISCT 2026 Annual Meeting take place?

  The ISCT 2026 Annual Meeting will be held from May 6-9, 2026, at the Convention Centre Dublin in Dublin, Ireland.

• What are the key themes of the ISCT 2026 Annual Meeting?

  Key themes include manufacturing innovations, clinical applications, gene editing, cell therapies, and biomanufacturing.

• Who are some of the key speakers at the ISCT 2026 Annual Meeting?

  Confirmed speakers include Frederic Cedrone (Catalent) and Mark Flower and Federica Mingotto (AGC Biologics).

• How can I get more information about the ISCT 2026 Annual Meeting?

  Visit the official ISCT website (isctglobal.org/annual-meeting) for the most up-to-date information, including the full conference program and registration details.

References

• Catalent - ISCT Annual Meeting
• AGC Biologics - ISCT 2026
• ISCT North America Virtual Town Hall
• BD Biosciences Events
• ISCT CGT Clinical Applications Program
• JSRM 25th Annual Meeting
• RegMedNet - Top Picks for ISCT 2026
• Cell and Gene Therapy CDMO Market to Hit Around USD 125.09 BN by 2035

Related coverage

• Cancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data
• KRX IR Reference : Executive Summary Plan for SCD NDR (ENG, Jun 2026)
• EMEA 2026 Life Sciences Report: Key Market Shifts for Pharma BD and Investors